Indivior (INDV)

Sector:

Pharma and Biotech

Index:

FTSE 250

101.10p
   
  • Change Today:
      1.35p
  • 52 Week High: 142.40
  • 52 Week Low: 34.00
  • Currency: UK Pounds
  • Shares Issued: 733.50m
  • Volume: 5,709,016
  • Market Cap: 741.57m
  • RiskGrade: 395

Indivior Overview

Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 22.7% -5.4%
ROCE 21.0%  
Latest F'cast
P/E 5.5 n/a
PEG n/a n/a
Pr/Revenue 1.2 1.6
Pr/Book 4.7  
Latest F'cast
Revenue -21.9% -56.3%
PBT -35.3% n/a
EPS -35.1% n/a
DPS n/a n/a

Indivior Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-15 1,014.00 285.00 34.00¢ 7.4 n/a -41% 12.70¢ 5.1%
31-Dec-16 1,058.00 98.00 35.00¢ 11.3 3.8 +3% n/a 0.0%
31-Dec-17 1,093.00 137.00 37.00¢ 14.7 2.5 +6% n/a 0.0%
31-Dec-18 1,005.00 278.00 37.00¢ 4.1 n/a n/a n/a 0.0%
31-Dec-19 785.00 180.00 24.00¢ 2.2 n/a -35% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Indivior Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 457.46 (24.68) (0.65)p n/a n/a n/a n/a 0.0%
31-Dec-21 463.72 64.99 7.33p 13.6 n/a n/a n/a 0.0%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

Latest Indivior Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Indivior Market Data

Currency UK Pounds
Share Price 101.10p
Change Today 1.35p
% Change 1.35 %
52 Week High 142.40
52 Week Low 34.00
Volume 5,709,016
Shares Issued 733.50m
Market Cap 741.57m
RiskGrade 395

Indivior Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.87% above the market average35.87% above the market average35.87% above the market average35.87% above the market average35.87% above the market average
92.59% above the sector average92.59% above the sector average92.59% above the sector average92.59% above the sector average92.59% above the sector average
Price Trend
80.63% above the market average80.63% above the market average80.63% above the market average80.63% above the market average80.63% above the market average
65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average
Income Not Available
Growth
74.87% below the market average74.87% below the market average74.87% below the market average74.87% below the market average74.87% below the market average
83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 4
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Indivior Dividends

No dividends found

Trades for 30-Nov-2020

Time Volume / Share Price
16:36 1,673 @ 101.10p
16:35 15,338 @ 101.10p
16:35 2,022,698 @ 101.10p
16:29 398 @ 101.70p
16:29 209 @ 101.70p

Indivior Key Personnel

CEO Mark Crossley
Chair Graham Hetherington

Top of Page